Effects of cholecystokinin-8 in peripheral neuropathies: a nerve growth factor mediated action?
Manni
L
L
Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden. l.manni@in.rm.cnr.it
Lundeberg
T
T
D000818:Animals; D005727:Ganglia, Spinal / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D020932:Nerve Growth Factor / Q000187:drug effects* / Q000378:metabolism; D009416:Nerve Regeneration / Q000187:drug effects* / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D012844:Sincalide / Q000494:pharmacology* / Q000627:therapeutic use; D017779:Sympathetic Fibers, Postganglionic / Q000187:drug effects / Q000378:metabolism / Q000473:pathology
D018696:Neuroprotective Agents; D020932:Nerve Growth Factor; D012844:Sincalide